loader2
Partner With Us NRI

Godavari Drugs Ltd share Price Today

Company details

98.27
102.40
76.21
114.00
6M Return 10.86%
1Y Return 29.34%
Mkt Cap.(Cr) 75.16
Volume 1,675
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,675

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Godavari Drugs Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (0)

Data not found

Opportunity (1)

  • Positive Breakout First Resistance ( LTP > R1)

Threats (2)

  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income

Resistance and support

R1 100.6
R2 102.3
R3 104.1
Pivot

98.81

S1 97.2
S2 95.4
S3 93.7
EMA SMA
98.6
98.6
98.2
95.6
97.8
98.9
98.6
97.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
PRASHANT SHRIMAL Bulk Sell 2023-06-15 93.52 41833 BSE
MOHIT JAJU Bulk Purchase 2023-06-06 87.99 70000 BSE
SUSHMA KAKANI Bulk Purchase 2023-06-06 88 70000 BSE
Name Category Shares
SUSHMA KAKANI PROMOTER 15.34%
KAMALA JAJU PROMOTER 12.08%
MOHIT JAJU PROMOTER 7.1%
GHANSHYAM JAJU PROMOTER 4.65%
MUKUND KAKANI PROMOTER 4.65%
AKSHEIT KAKANI PROMOTER 4.33%
PRIYANKA JAJU PROMOTER 2.46%
TANUSHREE KAKANI PROMOTER 1.86%
KIRTI KUMAR JAIN PROMOTER 0.66%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Godavari Drugs Ltd Stocks COMPARISON

Financials( in Cr) Godavari Drugs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 99.80 1,514.80 1,360.85 6,018.00 3,751.90
% Change 0.84 -1.64 0.44 0.03 0.39
Mcap Cr 75.16 363,451.27 109,870.54 100,391.07 99,601.31
Revenue TTM Cr 159.62 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 3.79 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 18.36 39.38 27.65 19.19 71.71
1 Year Return 29.34 54.71 50.70 25.22 17.51
ROCE 14.37 16.79 14.76 25.99 19.30
ROE 12.02 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 33.42 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,463.02 -3,609.06
LAST 3M 83,632.14 32,580.07
LAST 6M 140,794.69 70,960.51
LAST 12M 216,582.31 196,780.81

Godavari Drugs Ltd Information

Stock PE (TTM)
18.36
Promoter Holding
53.16%
Book Value
46.5908
ROCE
14.37%
ROE
12.02%
Description
  • Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API`s, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced `Pyrazyamide` in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of `Pyrazyamide` of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug. The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale to pilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.

Registered Address

Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003

Tel : 91-40-27849700/27844557
Email : info:godavaridrugs.com
Website : http://www.godavaridrugs.com
Registrar

CIL Securities Limited

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 530317
NSE Code :
Book Closure Date (Month) : Aug
BSE Group : X
ISIN : INE362C01012

FAQ’s on Godavari Drugs Ltd Shares

You can buy Godavari Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Godavari Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 23, 2024 11:26 AM the closing price of Godavari Drugs Ltd was ₹ 99.80.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 23, 2024 11:26 AM, the market cap of Godavari Drugs Ltd stood at ₹ 75.16.

The latest PE ratio of Godavari Drugs Ltd as of Apr 23, 2024 11:26 AM is 18.36

The latest PB ratio of Godavari Drugs Ltd as of Apr 23, 2024 11:26 AM is 0.47

The 52-week high of Godavari Drugs Ltd share price is ₹ 114.00 while the 52-week low is ₹ 76.21

Download Our

Download App
market app